skip to navigation skip to content

Thought leadership

Drug trials: what value should pharma firms assign to rivals’ success?

Drug companies pay close attention to early-stage investment and testing by rivals, but only successful demonstrations of clinical proof of concept really…

More…

Tapping ancient knowledge to solve very modern problems

Centuries-old experience and practices of Indigenous people can unleash biocultural innovation to help solve some of society’s biggest problems, says study co-authored…

More…

What type of negative emissions technologies should be prioritised?

Combating global warming will require removing carbon and not just reducing new emissions. A new study co-authored by Professor David Reiner of…

More…

Not having it all: why people renounce certain workplace ambitions

A new study co-authored by Dr Thomas Roulet of Cambridge Judge Business School examines the various ways people renounce goals or desires…

More…

Read more insight & opinion

#CJBSLife